Protego Biopharma
company
About
Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy.
- San Diego,California,United States
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $51.04M
- Industries
- Biopharma,Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Also Known As
- Misfolding Diagnostics, Inc.
Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$51.04M
Protego Biopharma has raised a total of
$51.04M
in funding over 2 rounds. Their latest funding was raised on
Oct 19, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 19, 2021 | Series A | $51.04M | 3 |
Lightspeed Venture Partners
Vida Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
3
Protego Biopharma is funded by 3 investors.
Lightspeed Venture Partners
and MPM Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lightspeed Venture Partners
|
Yes | Series A |
|
|
Yes | Series A |
|
Vida Ventures
|
Yes | Series A |
Employee Profiles
Number of Employee Profiles
4
Protego Biopharma has 4 current employee profiles, including
Board member Shelley Chu
Board member
Board member
Executive
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
